Post
Pharmaceutical Technology Excellence Awards 2023: Apprentice.io
Apprentice helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. Our …
Leading providers of product inspection, testing and detection equipment and services
The pharmaceutical industry demands the highest standards of product quality and safety. Inspection, testing, and detection equipment play a crucial …
Ono and Adimab partner to develop oncology antibody drugs
Ono Pharmaceutical and Adimab have signed a drug discovery collaboration agreement for the development of antibody drugs in the oncology …
Roche gains rights to Ionis’ Alzheimer’s and Huntington’s programmes
Roche has signed an agreement to attain exclusive global rights to Ionis Pharmaceuticals’ two early-stage programmes for Alzheimer’s disease and Huntington’s disease …
Tetra receives rare paediatric disease designation for FXS therapy
Shionogi Group company Tetra Therapeutics has received rare paediatric disease designation from the US Food and Drug Administration (FDA) for …
Ono and Adimab partner to develop oncology antibody drugs
Ono Pharmaceutical and Adimab have signed a drug discovery collaboration agreement for the development of antibody drugs in the oncology …
Roche gains rights to Ionis’ Alzheimer’s and Huntington’s programmes
Roche has signed an agreement to attain exclusive global rights to Ionis Pharmaceuticals’ two early-stage programmes for Alzheimer’s disease and Huntington’s disease …
Tetra receives rare paediatric disease designation for FXS therapy
Shionogi Group company Tetra Therapeutics has received rare paediatric disease designation from the US Food and Drug Administration (FDA) for …
Takeda’s Entyvio receives FDA approval for subcutaneous administration
Takeda has received approval from the US Food and Drug Administration (FDA) for subcutaneous (SC) administration of Entyvio (vedolizumab) to …
Glenmark to market Winlevi in Europe and South Africa after Cosmo deal
Glenmark has gained exclusive rights from Cosmo to commercialise the acne treatment Winlevi (clascoterone cream 1%) in Europe and South …
Avalyn raises $175m in funding to develop inhaled IPF drugs
Avalyn Pharma secured $175m in a Series C financing round to fund the clinical development of inhaled pulmonary therapies. The US-based …
Galecto downsizes by 70% following Phase II trial failure
Galecto has fired 70% of its workforce and is considering a whole list of strategic alternatives a month after announcing …
Novo Nordisk and Evotec launch translational drug discovery accelerator
Novo Nordisk has entered a partnership with Evotec to kickstart a drug discovery accelerator called LAB eN² that will combine the …
Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US
A District Judge sided with Eli Lilly yesterday (26 September), overturning a $176.5m jury ruling that it had infringed upon …
Generics expected to improve access for patients with idiopathic pulmonary fibrosis
The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments that are available globally, Roche’s Esbriet/Pirespa …